A phase II study of recombinant interferon-β (r-hIFN-β 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma

Joffe, JK, Perren, TJ orcid.org/0000-0001-8472-8856, Bradley, C et al. (5 more authors) (1997) A phase II study of recombinant interferon-β (r-hIFN-β 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma. British Journal of Cancer, 75 (3). pp. 423-426. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 1997 Cancer Research Campaign. This is article is distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License.
Keywords: interferon-beta; 5-fluorouracil; chemotherapy; colorectal carcinoma
Dates:
  • Published: February 1997
  • Accepted: 30 August 1996
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Oncology and Cancer Research - Labs (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 12 Jul 2016 10:02
Last Modified: 20 Mar 2019 16:15
Published Version: http://dx.doi.org/10.1038/bjc.1997.69
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/bjc.1997.69

Share / Export

Statistics